Edition:
United Kingdom

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

71.93USD
16 Aug 2019
Change (% chg)

$1.59 (+2.26%)
Prev Close
$70.34
Open
$70.77
Day's High
$72.66
Day's Low
$70.77
Volume
78,733
Avg. Vol
74,764
52-wk High
$106.23
52-wk Low
$64.25

About

Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for the treatment of viral infections and liver diseases. Its research and development programs are focused on three disease targets:... (more)

Overall

Beta: 0.95
Market Cap(Mil.): $1,507.29
Shares Outstanding(Mil.): 19.67
Dividend: --
Yield (%): --

Financials

  ENTA.OQ Industry Sector
P/E (TTM): 20.64 98.31 33.85
EPS (TTM): 3.71 -- --
ROI: 20.00 7.52 12.69
ROE: 20.23 7.94 17.13

Enanta's lung infection therapy succeeds in mid-stage trial

Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.

14 Jun 2019

UPDATE 1-Enanta's lung infection therapy succeeds in mid-stage trial

June 14 Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study.

14 Jun 2019

REFILE-Enanta's lung infection therapy succeeds in mid-stage trial

June 14 Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body and improving symptoms in patients in a mid-stage study.

14 Jun 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates